Resources

Article

January 11, 2023

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms.

Article

November 16, 2022

The Dual Sourcing Approach: How robust is your strategy? In today’s world, risk mitigation is a must.

Expert

November 16, 2022

Robotic Aseptic Processing: The Need for Technically Advanced Manufacturing & Specialized Packaging.

Expert

November 01, 2022

How one CDMO navigated the pandemic: Adversity, Adaption, Delivery, Expansion

Article

September 30, 2022

Dual Sourcing to Help Mitigate Risk in the Supply Chain: Interview with Alan Lahaise

Article

September 30, 2022

Robotic Sterile Fill-Finish Is Key for Speed to Clinic and Patient Safety.

Expert

September 13, 2022

EU regulation 536/2014: Key Considerations When Planning for the Return and Destruction of Your Product

Article

August 22, 2022

Packaging of Biologics and Specialty Medicines: Planning for a Seamless Transition from Clinic to Launch.

Whitepaper

July 15, 2022

Optimizing Your Clinical to Commercial Journey

Article

June 28, 2022

The challenges of handling and delivering highly potent oncology drugs

Article

June 01, 2022

Bridging the Gap: How PCI Pharma Services helps to bring life-changing therapies to patients

Expert

May 26, 2022

Trends Driving Opportunities & Outsourcing: Shawn Cain discusses pharma and biopharma outsourcing trends.

talkfuture@pci.com

Spanning the cycle. A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close.